Cancer Prevention Pharmaceuticals (Cancer Prevention Pharmaceuticals) Days Inventory : 0.00 (As of Mar. 2016)

View and export this data going back to 2016. Start your Free Trial

What is Cancer Prevention Pharmaceuticals Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Cancer Prevention Pharmaceuticals's Average Total Inventories for the three months ended in Mar. 2016 was $0.00 Mil. Cancer Prevention Pharmaceuticals's Cost of Goods Sold for the three months ended in Mar. 2016 was $0.00 Mil.

The historical rank and industry rank for Cancer Prevention Pharmaceuticals's Days Inventory or its related term are showing as below:

CPP's Days Inventory is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 159.35
* Ranked among companies with meaningful Days Inventory only.

Cancer Prevention Pharmaceuticals's Days Inventory stayed the same from Dec. 2014 (0.00) to Mar. 2016 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cancer Prevention Pharmaceuticals's Inventory-to-Revenue for the three months ended in Mar. 2016 was 0.00.

Cancer Prevention Pharmaceuticals Days Inventory Historical Data

The historical data trend for Cancer Prevention Pharmaceuticals's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cancer Prevention Pharmaceuticals Days Inventory Chart

Cancer Prevention Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Days Inventory

Cancer Prevention Pharmaceuticals Quarterly Data
	Dec13	Dec14	Mar15	Sep15	Dec15	Mar16
Days Inventory	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Cancer Prevention Pharmaceuticals's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Cancer Prevention Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cancer Prevention Pharmaceuticals's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cancer Prevention Pharmaceuticals's Days Inventory distribution charts can be found below:

* The bar in red indicates where Cancer Prevention Pharmaceuticals's Days Inventory falls into.

Cancer Prevention Pharmaceuticals Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cancer Prevention Pharmaceuticals's Days Inventory for the fiscal year that ended in Dec. 2015 is calculated as

	Days Inventory (A: Dec. 2015 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2014 )	+	Total Inventories (A: Dec. 2015 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2015 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Cancer Prevention Pharmaceuticals's Days Inventory for the quarter that ended in Mar. 2016 is calculated as:

	Days Inventory (Q: Mar. 2016 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Dec. 2015 )	+	Total Inventories (Q: Mar. 2016 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2016 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Cancer Prevention Pharmaceuticals (AMEX:CPP) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cancer Prevention Pharmaceuticals's Inventory Turnover for the three months ended in Mar. 2016 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cancer Prevention Pharmaceuticals's Inventory to Revenue for the three months ended in Mar. 2016 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	1.038
	=	0.00

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Cancer Prevention Pharmaceuticals Days Inventory Related Terms

Thank you for viewing the detailed overview of Cancer Prevention Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Cancer Prevention Pharmaceuticals (Cancer Prevention Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cancer Prevention Pharmaceuticals Inc (AMEX:CPP) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.canprevent.com

Cancer Prevention Pharmaceuticals Inc is a pharmaceutical company. It was originally incorporated under the laws of the state of Arizona on June 9, 2008, as Cancer Prevention Pharmaceuticals, LLC and on December 22, 2009, Cancer Prevention Pharmaceuticals, Inc. was incorporated in the state of Delaware. The Company currently operates mainly in the development and commercialization of compound CPP-1X, otherwise known as DFMO or eflornithine. It is involved in familial adenomatous polyposis, neuroblastoma and the prevention of recurrence in colon cancer survivors. However, CPP also has therapeutic prevention approaches for prostate cancer, breast cancer, and skin cancers which will be developed together with the National Cancer Institute (as resources become available in the future) and multiple academic partners. Its competitors are Marina Biotech, Inc., SLA Pharma AG, StemSynergy Therapeutics, Inc. and Thetis Pharmaceuticals LLC. The Company holds license to approximately six issued patents in the United States. The Company's activities are subject to risks and uncertainties including failure to obtain required regulatory approvals to market the products, once developed, in the USA or foreign markets.